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Introduction
Antibodies to Hepatitis C virus (anti-HCV) are detectable by enzyme-immunoassay (EIA) and recombinant immunoblot assay (RIBA). Second-generation of both assays incorporate three recombinant HCV antigens (c100-3, c33c and 5-1-1) encoded by the nostructural region of the HCV genome, and one antigen (c22-3) which represents core protein, encoded by C gene (1) . EIA test may give false-positive results due to possible nonspecifi c reactivity, especially to c100-3 antigen (13) . Immunoblot RIBA test may detect antibodies to individual HCV antigens, and RIBA reactivity gave an additional indication that the reactivity by EIA was specifi c for HCV antibody. It is positive if the serum is reactive to at least two antigens (one structural and one non-structural). The persistence of detectable antibodies to HCV antigens may refl ect either a past resolved infection or chronic persistent infection associated with liver histologic lesions. Usually, RIBA positivity is associated with chronic infection as assessed by polimerase chain reaction (PCR) (7, 18) . However, some subjects have antibodies reacting to a single recombinant antigen, which is considered an indeterminate result (15, 16) .
The aim of our study was to determine: 1) the prevalence of RIBA indeterminate subjects, and 2) the correlation between RIBA indeterminate result and viremia according to the presence of normal or increased ALT levels.
Materials and Methods
This study included 198 subjects who were anti-HCV-positive by EIA HCV 2.0 for more than one year. All the patients were tested with RIBA HCV 2.0 (Ortho Diagnostic). In this assay HCV antigens (c100-3, c33c, 5-1-1 and c22-3) are fi xed to a nitrocellulose fi lter, along with control protein-human superoxid dismutase (h SOD band).The test is based on the immuno-enzyme reaction principle. The serum reactivity to individual antigen is determined by the color intensity which may be expressed as 1+, 2+, 3+ and 4+. An indeterminate RIBA 2 was defi ned as any single HCV band having 1+ or greater reactivity and a negative h SOD band.
The subjects found to be RIBA 2 indeterminate were included into further study. All of them were anti-HIV-negative. In all RIBA 2 indeterminate patients HCV RNA was detected, and serum alanine aminotransferase (ALT) was measured. HCV RNA was detected by reverse-transcription polymerase chain reaction-RT-PCR (Aplicor, Roche Diagnostic Systems, Branchburg, NJ). This assay was carried out according to the manufacturer's instructions. The same serum sample was used for EIA, RIBA 2, RT-PCR and ALT measuring. All serum samples were coded, made uniform, and stored at -70ºC until analysis.
The data were processed using Epi Info (Ver.6.04) Software. To compare the distribution of reactivity to individual HCV antigens, x 2 test was used. The analysis of HCV RNA prevalence, according to the ALT level, was assessed by x 2 (with 
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Results and Discussion
An indeterminate RIBA 2 was found in 30 (15.15%) of subjects. No single reactivity to antigen 5-1-1 was found in any subject. Comparing the distribution of c100-3, c22-3 and c33c reactivity, we found the reactivity to c22-3 to be the most frequent (p<0.01).See Table 1 . Table 2 . Due to a small number of HCV RNA positive subjects reactive to c100-3 and c33c, we could not determine if there was a signifi cant correlation between the presence of HCV RNA and c 22-3 reactivity. HCV RNA positive results according to ALT levels and to antigen reactivity are shown in Table 3 . All the RIBA indeterminate patients with elevated ALT levels were HCV RNA positive. In patients with normal ALT 15.3% were HCV RNA positive. The prevalence of viremia was signifi cantly higher in patients with elevated ALT than in those with normal ALT levels (p<0.001). A second-generation RIBA test is used as a confi rmatory test in EIA anti-HCV-positive subjects. The most of anti-HCVpositive patients with chronic hepatitis C are RIBA 2 positive (11). Also, RIBA positive result is signifi cantly associated with the presence of HCV RNA (HCV viremia) detected by PCR.
Previous studies have shown that the correlation between RIBA 2 positive result and detection of HCV RNA range from 72 to 100%. In addition, most patients or blood donors who are RIBA 2 negative are also PCR negative (19) . However, indeterminate RIBA 2 results are more problematic. This category can include false-positive reactivity, past and resolved infection, early seroconvertion to acute infection, or chronic HCV infection.(10) Some previous reports have demonstrated that the prevalence of RIBA 2 indeterminate results ranges from 14 to 23% (12, 14) . It is more frequent in anti HIV positive patients.
In our study, 15.15% of anti-HCV-positive, anti-HIVnegative subjects were RIBA 2 indeterminate. Due to the fact that they were EIA-positive for more than one year we supposed that it was a chronic persistent infection, resolved chronic infection or false positive result. The majority of RIBA indeterminate subjects were only anti-c22-3-positive (70%). Our result is in agreement with the result of Marcelin et al. (12) , who found anti-c22-3 in 71% of RIBA indeterminate subjects. This result may be explained by the fact that antic22-3 antibodies persist longer than the others, after resolution of infection (3). Besides, anti-c22-3 are antibodies to core protein, which is highly conserved among the different HCV genotypes, so they can be detected in patients infected with different genotypes (9) .
To evaluate the viremia in RIBA indeterminate subjects we performed RT-PCR for HCV RNA detection. HCV RNA was detected in 63.3% of subjects. The most of HCV RNA positive patients were anti-c22-3 positive (78.9%). Our result is in agreement with the previous studies which have demonstrated that the prevalence of HCV RNA in RIBA 2 indeterminate patients ranges from 50 to 70%. The most of previous examinations also showed that reactivity to c22-3 has been frequently associated with detectable HCV RNA (2, 5, 17) . Opposite to that, there was report that reactivity to c33c antigen exhibited the strongest correlation with HCV RNA (14) . In HCV RNA positive patients with persistent infection, RIBA indeterminate result can be explained by the poor humoral immune response or infection by different HCV genotypes. Among patients included in our study, 5 were on long-term hemodialysis, and they were considered immunosupressed. The correlation between singular reactivity and viral genotype has been reported. Dow showed that RIBA may be less sensitive in genotype 2 and 3 infections, because the assay is based on viral proteins encoded by HCV genotype 1 a (6). Opposite to that, the fi nding of recent study has not suggested that indeterminate results are more common in genotype 2 and 3 compared to genotype 1 (4) .
Analyzing the PCR results according to ALT level we found that all patients with elevated ALT levels were PCR positive. Also, 2 (15.3%) patients with normal ALT level were also PCR positive. These two patients were on hemodialysis. Their medical histories demonstrated long-term presence of normal
